Updates are available Correction dated 2021-02-26
Click to view Correction: https://doi.org/10.1038/s41588-021-00822-1
-
Authors
Schwartzentruber, Jeremy http://orcid.org/0000-0002-6183-2092
Cooper, Sarah
Liu, Jimmy Z.
Barrio-Hernandez, Inigo http://orcid.org/0000-0002-5686-0451
Bello, Erica
Kumasaka, Natsuhiko http://orcid.org/0000-0002-3557-0375
Young, Adam M. H.
Franklin, Robin J. M.
Johnson, Toby
Estrada, Karol
Gaffney, Daniel J. http://orcid.org/0000-0002-1529-1862
Beltrao, Pedro http://orcid.org/0000-0002-2724-7703
Bassett, Andrew http://orcid.org/0000-0003-1632-9137
-
Funding
Funding for this research was provided by:
Multiple Sclerosis Society (50, 50)
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
Wellcome Trust (203151/Z/16/Z, PhD for clinicians fellowship, 203151/Z/16/Z)
- License Information
-
More Information
Article History
Received: 16 January 2020
Accepted: 23 December 2020
First Online: 15 February 2021
Change Date: 26 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41588-021-00822-1
Competing interests
: J.Z.L. was an employee of Biogen at the time of the study and is now an employee of GSK. D.J.G. is an employee of Genomics PLC. T.J. is an employee of GSK. K.E. is an employee of BioMarin Pharmaceutical.
